With over 18 years in Medtech, Edna Lazar is an accomplished MedTech investor with experience in identifying and nurturing promising startups. Joining JJDC EMEA in 2024, Edna brings a wealth of experience in early-stage investments, both from the investor and start up side.
With over 18 years in Medtech, Edna Lazar is an accomplished MedTech investor with experience in identifying and nurturing promising startups. Joining JJDC EMEA in 2024, Edna brings a wealth of experience in early-stage investments, both from the investor and start up side.
Prior to joining JJDC, Edna was a member of the Exploration team at Edwards Lifesciences, focusing on strategic investment opportunities within the structural heart disease and heart failure space. Prior to this role, Edna served as Chief Business Officer at MEDX Xelerator, where she led the identification, assessment, and investment in innovative medical device projects across multiple therapeutic areas.
With a strong foundation in business development and marketing, Edna has held executive positions in Israeli startups operating in the Diabetes and GI spaces. Her career journey began at J&J Diabetes franchise at LifeScan, where she served as a Marketing Manager.
Edna was a practicing commercial law attorney and holds an LLB from the Hebrew University in Jerusalem and an MBA from the Kellogg School of Management at Northwestern University.
With over 18 years in Medtech, Edna Lazar is an accomplished MedTech investor with experience in identifying and nurturing promising startups. Joining JJDC EMEA in 2024, Edna brings a wealth of experience in early-stage investments, both from the investor and start up side, in small and established companies, located in Israel and in the US.
Prior to joining JJDC, Edna was a member of the Exploration team at Edwards Lifesciences, focusing on strategic investment opportunities within the structural heart disease and heart failure space. Prior to this role, Edna served as Chief Business Officer at MEDX Xelerator, where she led the identification, assessment, and investment in innovative medical device projects across multiple therapeutic areas.
With a strong foundation in business development and marketing, Edna has held executive positions in Israeli startups operating in the Diabetes and GI spaces. Her career journey began at J&J Diabetes franchise at LifeScan, where she served as a Marketing Manager.
Edna was a practicing commercial law attorney and holds an LLB from the Hebrew University in Jerusalem and an MBA from the Kellogg School of Management at Northwestern University.
Education:
LLB Hebrew University, Jerusalem Israel
MBA, Kellogg School of Management, Northwestern University
Achievements
Member, Humanitarian Delegation to Rwanda, IDF Medical Corps
Certificate of Honor, Israel Bar Association, Pro Bono Program
Health Industry Management Alumni Board Scholarship, Kellogg School of Management
Stanford Biodesign Executive Education Program
Mentor, Israeli Biodesign Program, Technion, Israel
Revised New version v1
Edna Lazar is a Principal with the JJDC MedTech investing team covering EMEA. Joining the team in 2024, Edna specializes in identifying promising startups in the strategic focus of J&J and moving them through the deal funnel, investment and post investment process. Edna brings a wealth of experience in early-stage investments, both from the investor and startup side.
Prior to joining JJDC, Edna was a member of the Exploration team at Edwards Lifesciences, focusing on strategic investment opportunities within the structural heart disease and heart failure space. Before this role, she served as Chief Business Officer at MEDX Xelerator, where she led the identification, assessment, and investment in innovative medical device projects across multiple therapeutic areas. Earlier in her career Edna has held executive positions in Israeli startups operating in the Diabetes and GI spaces, leveraging her strong foundation in business development and marketing. Her career journey began at J&J Diabetes franchise at LifeScan, where she served as a Marketing Manager.
Edna was a practicing commercial law attorney and holds an LLB from the Hebrew University in Jerusalem and an MBA from the Kellogg School of Management at Northwestern University.
Edna is located at JJDC’s office outside of Tel Aviv, Israel.
Revised New Version v2
Edna Lazar is a Principal with the JJDC MedTech investing team, covering the EMEA region. Edna specializes in identifying promising startups aligned with J&J’s strategic focus, driving them through the deal funnel, investment, and post-investment processes. She brings extensive experience in early-stage investments from both the investor and startup perspectives.
Before joining JJDC, Edna was part of the Exploration team at Edwards Lifesciences, where she focused on strategic investment opportunities in the structural heart disease and heart failure sectors. She also served as Chief Business Officer at MEDX Xelerator, leading the identification, assessment, and investment in innovative medical device projects across various therapeutic areas. Earlier in her career, Edna held executive positions in Israeli startups within the Diabetes and GI fields, leveraging her strong background in business development and marketing. Her career began at J&J’s LifeScan Diabetes franchise, where she worked as a Marketing Manager.
Edna holds an LLB from the Hebrew University in Jerusalem and an MBA from the Kellogg School of Management at Northwestern University. She is based at JJDC’s office in Israel.
Revised New Version v3
Edna Lazar is a Principal with the JJDC MedTech investing team, covering the EMEA region. Edna specializes in identifying promising startups aligned with J&J’s strategic focus, driving them through the deal funnel, investment, and post-investment processes. She brings extensive experience in early-stage investments from both the investor and startup perspectives.
Before joining JJDC, Edna was part of the Exploration team at Edwards Lifesciences, where she focused on strategic investment opportunities in the structural heart disease and heart failure sectors. She also served as Chief Business Officer at MEDX Xelerator, leading the identification, assessment, and investment of seven innovative medical device startups across various therapeutic areas. Earlier in her career, Edna held executive positions in Israeli startups within the Diabetes and GI fields, leveraging her strong background in business development and marketing. Her career began at J&J’s LifeScan Diabetes franchise, where she worked as a Marketing Manager during a period of three product launches.
Edna holds an LLB from the Hebrew University in Jerusalem and an MBA from the Kellogg School of Management at Northwestern University, where she was honored with the Health Industry Management Alumni Board Scholarship. She has also completed the Stanford Biodesign Executive Education Program. Additionally, she serves as a mentor for the Israeli Biodesign Program at the Technion in Israel and the Israeli Society of Healthtech physician fellowship
Edna is based at JJDC’s office in Israel.